Vasilis Stenos
CEO

The startup develops climate technology and biotechnology that converts industrial carbon dioxide into protein and other essential ingredients, addressing global food scarcity and energy needs. By utilizing CO2 as a raw material, the company enables sustainable production methods that contribute to a net-zero economy.
Raised to date
$5.3MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

Current industrial practices contribute significantly to carbon dioxide emissions, exacerbating climate change and environmental degradation. Simultaneously, the growing global population necessitates innovative and sustainable methods for producing food and essential ingredients.
Solmeyea offers a climate technology and biotechnology platform that converts industrial carbon dioxide emissions into valuable protein, bioactive pigments, and natural oils using a proprietary microalgae cultivation process. Their patented CO2 bioconversion technology utilizes a hybrid vertical farming platform, combining fermentors and glass tubular photobioreactors, to efficiently transform CO2 into carbon-negative ingredients. This process enables the production of sustainable, non-GMO, animal-free alternatives for various applications, including food, feed, cosmetics, and pharmaceuticals. By valorizing CO2 as a raw material, Solmeyea addresses both environmental concerns and the increasing demand for sustainable resources.
Solmeyea's primary customers include FMCG (Fast-Moving Consumer Goods) companies, plant-based food manufacturers, cosmetic formulators, and pharmaceutical companies seeking sustainable and carbon-negative ingredients.